D'Orazio & Associates’s Exact Sciences EXAS Stock Holding History

D'Orazio & Associates’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-40	Closed	-$4K	–	297
2021 Q3	$4K	Hold	40	–	–	﹤0.01%	651
2021 Q2	$5K	Hold	40	–	–	﹤0.01%	344
2021 Q1	$5K	Hold	40	–	–	﹤0.01%	322
2020 Q4	$5K	Hold	40	–	–	﹤0.01%	300
2020 Q3	$4K	Hold	40	–	–	﹤0.01%	273
2020 Q2	$3K	Hold	40	–	–	﹤0.01%	293
2020 Q1	$2K	Hold	40	–	–	﹤0.01%	294
2019 Q4	$4K	Hold	40	–	–	﹤0.01%	288
2019 Q3	$4K	Hold	40	–	–	﹤0.01%	288
2019 Q2	$5K	Hold	40	–	–	﹤0.01%	275
2019 Q1	$3K	Hold	40	–	–	﹤0.01%	295
2018 Q4	$3K	Hold	40	–	–	﹤0.01%	260
2018 Q3	$3K	Buy	+40	New	+$2.61K	﹤0.01%	248

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

D'Orazio & Associates's EXAS Position: Q4 2021 in Review

D'Orazio & Associates sold out of Exact Sciences (EXAS) in Q4 2021, closing a stake of 40 shares — an estimated $4K sold.

D'Orazio & Associates first reported a position in EXAS in Q3 2018 and held it in 13 quarters. The position peaked at $5K in Q2 2021. 596 funds tracked by Wall St. Rank hold EXAS as of Q4 2021.

D'Orazio & Associates reported no remaining Exact Sciences position as of Q4 2021 after selling out during the quarter.
D'Orazio & Associates sold 40 Exact Sciences shares in Q4 2021, an estimated $4K.
D'Orazio & Associates first reported a position in Exact Sciences in Q3 2018 and held it in 13 quarters.
D'Orazio & Associates's Exact Sciences position peaked at $5K in Q2 2021.
596 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2021.

Based on D'Orazio & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.